- Home
- RBKB vs ANVS Comparison
RBKB vs ANVS Comparison
Compare RBKB & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBKB
- ANVS
- Stock Information
- Founded
- RBKB 1860
- ANVS 2008
- Country
- RBKB United States
- ANVS United States
- Employees
- RBKB N/A
- ANVS N/A
- Industry
- RBKB Banks
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- RBKB Finance
- ANVS Health Care
- Exchange
- RBKB Nasdaq
- ANVS Nasdaq
- Market Cap
- RBKB 92.6M
- ANVS 110.4M
- IPO Year
- RBKB 2019
- ANVS 2020
- Fundamental
- Price
- RBKB $9.63
- ANVS $6.85
- Analyst Decision
- RBKB
- ANVS Strong Buy
- Analyst Count
- RBKB 0
- ANVS 6
- Target Price
- RBKB N/A
- ANVS $29.67
- AVG Volume (30 Days)
- RBKB 7.5K
- ANVS 261.0K
- Earning Date
- RBKB 10-24-2024
- ANVS 11-08-2024
- Dividend Yield
- RBKB N/A
- ANVS N/A
- EPS Growth
- RBKB N/A
- ANVS N/A
- EPS
- RBKB N/A
- ANVS N/A
- Revenue
- RBKB $29,243,000.00
- ANVS N/A
- Revenue This Year
- RBKB N/A
- ANVS N/A
- Revenue Next Year
- RBKB N/A
- ANVS N/A
- P/E Ratio
- RBKB N/A
- ANVS N/A
- Revenue Growth
- RBKB N/A
- ANVS N/A
- 52 Week Low
- RBKB $6.10
- ANVS $4.53
- 52 Week High
- RBKB $9.81
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- RBKB 65.77
- ANVS 30.84
- Support Level
- RBKB $9.46
- ANVS $7.30
- Resistance Level
- RBKB $9.74
- ANVS $8.93
- Average True Range (ATR)
- RBKB 0.25
- ANVS 0.56
- MACD
- RBKB 0.04
- ANVS -0.26
- Stochastic Oscillator
- RBKB 87.67
- ANVS 4.89
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.